2617 — TransThera Sciences (Nanjing) Balance Sheet
0.000.00%
Last trade - 00:00- HK$79.62bn
- HK$78.92bn
Annual balance sheet for TransThera Sciences (Nanjing), fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Cash | ||
| Short Term Investments | ||
| Cash and Short Term Investments | 838 | 573 |
| Net Total Receivables | 0.602 | 0.456 |
| Total Inventory | ||
| Prepaid Expenses | ||
| Total Other Current Assets | ||
| Total Current Assets | 846 | 585 |
| Gross Property, Plant And Equipment | ||
| Accumulated Depreciation | ||
| Net Property, Plant And Equipment | 31.6 | 28.8 |
| Net Intangible Assets | ||
| Long Term Notes Receivable | ||
| Other Long Term Assets | ||
| Total Assets | 887 | 630 |
| Accounts Payable | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Current Portion of Long Term Debt / Capital Leases | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 103 | 103 |
| Capital Lease Obligations | ||
| Total Long Term Debt | ||
| Total Debt | ||
| Total Liabilities | 104 | 105 |
| Common Stock | ||
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| ESOP Debt Guarantee | ||
| Other Equity | ||
| Total Equity | 783 | 525 |
| Total Liabilities & Shareholders' Equity | 887 | 630 |
| Total Common Shares Outstanding |